Skip to main content

Shalini Sharp

Equibles does not estimate personal net worth.

About Shalini Sharp

Earlier roles on record: CFO at Ultragenyx Pharmaceutical Inc. (RARE) until November 2, 2020. The proxy statement of Ultragenyx Pharmaceutical Inc. reports total compensation of $793,249 for Shalini Sharp in fiscal 2020, including a base salary of $499,638. Disclosed compensation is on record for 4 fiscal years. Shalini Sharp has spoken on 3 earnings calls across 1 company, most recently for Ultragenyx Pharmaceutical Inc. on October 27, 2020. The companies whose calls Shalini Sharp spoke on are classified in the Healthcare sector.

Shalini Sharp on recent calls

“Well, thank you so much, Emil, and good afternoon to everybody. I am delighted to join you all for our last quarterly conference call.”
CFO, Ultragenyx Pharmaceutical Inc. Q3 FY2020 Earnings Call ·
“We issued a press release earlier today that included a financial update, which I will briefly summarize. Total revenue for the 3 months ending June 30, 2020, was $61.7 million.”
CFO, Ultragenyx Pharmaceutical Inc. Q2 FY2020 Earnings Call ·
“Earlier today, we issued a press release that included a financial update, which I will briefly summarize. Total revenue for the three months ending March 31, 2020, was $36.3 million.”
CFO, Ultragenyx Pharmaceutical Inc. Q1 FY2020 Earnings Call ·

Affiliation history

Company network

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2020 Ultragenyx Pharmaceutical Inc. (RARE) $499,638 $793,249
2019 Ultragenyx Pharmaceutical Inc. (RARE) $484,548 $2,572,184
2018 Ultragenyx Pharmaceutical Inc. (RARE) $470,435 $2,027,960
2017 Ultragenyx Pharmaceutical Inc. (RARE) $455,785 $2,642,719

Recent activity